Literature DB >> 11141536

Antipsychotic dosing patterns for schizophrenia in three treatment settings.

G Remington1, C M Shammi, R Sethna, R Lawrence.   

Abstract

Daily dosages of antipsychotic medications were evaluated to determine whether current guidelines advocating lower dosing are being followed. A chart review of 163 outpatients with schizophrenia was undertaken in three outpatient hospital settings-a general community hospital, a provincial hospital, and an academic teaching hospital. The daily dosage in chlorpromazine equivalents was significantly higher in the provincial hospital (773.8 mg) than in the community hospital (355 mg) or the academic hospital (424.8 mg). A greater proportion of patients at the provincial hospital received conventional antipsychotics than novel antipsychotics or depot antipsychotics, and a greater proportion received more than one antipsychotic.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11141536     DOI: 10.1176/appi.ps.52.1.96

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  4 in total

Review 1.  Antipsychotic polypharmacy in schizophrenia: benefits and risks.

Authors:  Thomas R E Barnes; Carol Paton
Journal:  CNS Drugs       Date:  2011-05       Impact factor: 5.749

2.  Prescribing patterns of long-acting injectable antipsychotics in a community setting in South Africa.

Authors:  Nabila Veyej; Mahomed Y H Moosa
Journal:  S Afr J Psychiatr       Date:  2022-06-30       Impact factor: 1.242

3.  Assessing conformance to medication treatment guidelines for schizophrenia in a community mental health center (CMHC).

Authors:  Mona Goldman; Daniel J Healy; Timothy Florence; Lorelei Simpson; Karen K Milner
Journal:  Community Ment Health J       Date:  2003-12

Review 4.  Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations.

Authors:  Giuseppe Rossi; Sonia Frediani; Roberta Rossi; Andrea Rossi
Journal:  BMC Psychiatry       Date:  2012-08-21       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.